Regenerative Medicine Market in Japan 2024-2028

Regenerative Medicine Market In Japan 2024-2028


The regenerative medicine market in japan is forecasted to grow by USD 3474.5 mn during 2023-2028, accelerating at a CAGR of 19.31% during the forecast period. The report on the regenerative medicine market in japan provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of stem cell therapy, rising prevalence of chronic diseases, and increasing aging population.

Technavio's regenerative medicine market in japan is segmented as below:
  • By Application
  • Oncology
  • Musculoskeletal
  • Dermatology
  • Others
  • By Technology
  • Cell and tissue-based
  • Gene therapy
  • By Geographical Landscape
  • APAC
This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicine market in japan growth during the next few years. Also, growing mergers and acquisitions by market vendors and development of induced pluripotent stem cells will lead to sizable demand in the market.

The report on the regenerative medicine market in japan covers the following areas:
  • Regenerative medicine market in japan sizing
  • Regenerative medicine market in japan forecast
  • Regenerative medicine market in japan industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicine market in japan vendors that include Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Corp., HEALIOS K.K., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., MEDINET Co. Ltd., Metcela Inc., Nikon Corp., ROHTO Pharmaceutical Co. Ltd, Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp.. Also, the regenerative medicine market in japan analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan: Year-over-year growth 2023-2028 (%)
Data Table on Japan: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Regenerative Medicine Market in Japan 2018 - 2022
Historic Market Size - Data Table on Regenerative Medicine Market in Japan 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Technology segment analysis 2018 - 2022
Historic Market Size - Technology Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2023-2028
Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Chart on Oncology - Year-over-year growth 2023-2028 (%)
Data Table on Oncology - Year-over-year growth 2023-2028 (%)
6.4 Musculoskeletal - Market size and forecast 2023-2028
Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%)
6.5 Dermatology - Market size and forecast 2023-2028
Chart on Dermatology - Market size and forecast 2023-2028 ($ million)
Data Table on Dermatology - Market size and forecast 2023-2028 ($ million)
Chart on Dermatology - Year-over-year growth 2023-2028 (%)
Data Table on Dermatology - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Technology
7.1 Market segments
Chart on Technology - Market share 2023-2028 (%)
Data Table on Technology - Market share 2023-2028 (%)
7.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
7.3 Cell and tissue-based - Market size and forecast 2023-2028
Chart on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Data Table on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Chart on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
Data Table on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
7.4 Gene therapy - Market size and forecast 2023-2028
Chart on Gene therapy - Market size and forecast 2023-2028 ($ million)
Data Table on Gene therapy - Market size and forecast 2023-2028 ($ million)
Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Technology
Market opportunity by Technology ($ million)
Data Table on Market opportunity by Technology ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key offerings
11.4 Becton Dickinson and Co.
Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
11.5 CellSeed Inc.
CellSeed Inc. - Overview
CellSeed Inc. - Product / Service
CellSeed Inc. - Key offerings
11.6 Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K. - Overview
Cyfuse Biomedical K.K. - Product / Service
Cyfuse Biomedical K.K. - Key offerings
11.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.8 FUJIFILM Corp.
FUJIFILM Corp. - Overview
FUJIFILM Corp. - Business segments
FUJIFILM Corp. - Key news
FUJIFILM Corp. - Key offerings
FUJIFILM Corp. - Segment focus
11.9 iHeart Japan Corp.
iHeart Japan Corp. - Overview
iHeart Japan Corp. - Product / Service
iHeart Japan Corp. - Key offerings
11.10 JCR Pharmaceticals Co. Ltd.
JCR Pharmaceticals Co. Ltd. - Overview
JCR Pharmaceticals Co. Ltd. - Product / Service
JCR Pharmaceticals Co. Ltd. - Key offerings
11.11 Nikon Corp.
Nikon Corp. - Overview
Nikon Corp. - Business segments
Nikon Corp. - Key offerings
Nikon Corp. - Segment focus
11.12 ROHTO Pharmaceutical Co. Ltd
ROHTO Pharmaceutical Co. Ltd - Overview
ROHTO Pharmaceutical Co. Ltd - Business segments
ROHTO Pharmaceutical Co. Ltd - Key offerings
ROHTO Pharmaceutical Co. Ltd - Segment focus
11.13 Sumitomo Pharma Co. Ltd.
Sumitomo Pharma Co. Ltd. - Overview
Sumitomo Pharma Co. Ltd. - Business segments
Sumitomo Pharma Co. Ltd. - Key offerings
Sumitomo Pharma Co. Ltd. - Segment focus
11.14 Takara Bio Inc.
Takara Bio Inc. - Overview
Takara Bio Inc. - Product / Service
Takara Bio Inc. - Key news
Takara Bio Inc. - Key offerings
11.15 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
11.16 Terumo Corp.
Terumo Corp. - Overview
Terumo Corp. - Business segments
Terumo Corp. - Key news
Terumo Corp. - Key offerings
Terumo Corp. - Segment focus
11.17 Yokogawa Electric Corp.
Yokogawa Electric Corp. - Overview
Yokogawa Electric Corp. - Business segments
Yokogawa Electric Corp. - Key news
Yokogawa Electric Corp. - Key offerings
Yokogawa Electric Corp. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Application
Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits6: Executive Summary - Chart on Company Market Positioning
Exhibits7: Parent Market
Exhibits8: Data Table on - Parent Market
Exhibits9: Market characteristics analysis
Exhibits10: Value Chain Analysis
Exhibits11: Offerings of companies included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits14: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits15: Chart on Japan: Year-over-year growth 2023-2028 (%)
Exhibits16: Data Table on Japan: Year-over-year growth 2023-2028 (%)
Exhibits17: Historic Market Size - Data Table on Regenerative Medicine Market in Japan 2018 - 2022 ($ million)
Exhibits18: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
Exhibits20: Five forces analysis - Comparison between 2023 and 2028
Exhibits21: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits23: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits24: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits25: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits26: Chart on Market condition - Five forces 2023 and 2028
Exhibits27: Chart on Application - Market share 2023-2028 (%)
Exhibits28: Data Table on Application - Market share 2023-2028 (%)
Exhibits29: Chart on Comparison by Application
Exhibits30: Data Table on Comparison by Application
Exhibits31: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits32: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits33: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits34: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits35: Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibits36: Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibits37: Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Exhibits38: Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Exhibits39: Chart on Dermatology - Market size and forecast 2023-2028 ($ million)
Exhibits40: Data Table on Dermatology - Market size and forecast 2023-2028 ($ million)
Exhibits41: Chart on Dermatology - Year-over-year growth 2023-2028 (%)
Exhibits42: Data Table on Dermatology - Year-over-year growth 2023-2028 (%)
Exhibits43: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits44: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits45: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits47: Market opportunity by Application ($ million)
Exhibits48: Data Table on Market opportunity by Application ($ million)
Exhibits49: Chart on Technology - Market share 2023-2028 (%)
Exhibits50: Data Table on Technology - Market share 2023-2028 (%)
Exhibits51: Chart on Comparison by Technology
Exhibits52: Data Table on Comparison by Technology
Exhibits53: Chart on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Gene therapy - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits61: Market opportunity by Technology ($ million)
Exhibits62: Data Table on Market opportunity by Technology ($ million)
Exhibits63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits64: Impact of drivers and challenges in 2023 and 2028
Exhibits65: Overview on criticality of inputs and factors of differentiation
Exhibits66: Overview on factors of disruption
Exhibits67: Impact of key risks on business
Exhibits68: Companies covered
Exhibits69: Matrix on companies position and classification
Exhibits70: Astellas Pharma Inc. - Overview
Exhibits71: Astellas Pharma Inc. - Product / Service
Exhibits72: Astellas Pharma Inc. - Key offerings
Exhibits73: Becton Dickinson and Co. - Overview
Exhibits74: Becton Dickinson and Co. - Business segments
Exhibits75: Becton Dickinson and Co. - Key news
Exhibits76: Becton Dickinson and Co. - Key offerings
Exhibits77: Becton Dickinson and Co. - Segment focus
Exhibits78: CellSeed Inc. - Overview
Exhibits79: CellSeed Inc. - Product / Service
Exhibits80: CellSeed Inc. - Key offerings
Exhibits81: Cyfuse Biomedical K.K. - Overview
Exhibits82: Cyfuse Biomedical K.K. - Product / Service
Exhibits83: Cyfuse Biomedical K.K. - Key offerings
Exhibits84: F. Hoffmann La Roche Ltd. - Overview
Exhibits85: F. Hoffmann La Roche Ltd. - Business segments
Exhibits86: F. Hoffmann La Roche Ltd. - Key news
Exhibits87: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits88: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits89: FUJIFILM Corp. - Overview
Exhibits90: FUJIFILM Corp. - Business segments
Exhibits91: FUJIFILM Corp. - Key news
Exhibits92: FUJIFILM Corp. - Key offerings
Exhibits93: FUJIFILM Corp. - Segment focus
Exhibits94: iHeart Japan Corp. - Overview
Exhibits95: iHeart Japan Corp. - Product / Service
Exhibits96: iHeart Japan Corp. - Key offerings
Exhibits97: JCR Pharmaceticals Co. Ltd. - Overview
Exhibits98: JCR Pharmaceticals Co. Ltd. - Product / Service
Exhibits99: JCR Pharmaceticals Co. Ltd. - Key offerings
Exhibits100: Nikon Corp. - Overview
Exhibits101: Nikon Corp. - Business segments
Exhibits102: Nikon Corp. - Key offerings
Exhibits103: Nikon Corp. - Segment focus
Exhibits104: ROHTO Pharmaceutical Co. Ltd - Overview
Exhibits105: ROHTO Pharmaceutical Co. Ltd - Business segments
Exhibits106: ROHTO Pharmaceutical Co. Ltd - Key offerings
Exhibits107: ROHTO Pharmaceutical Co. Ltd - Segment focus
Exhibits108: Sumitomo Pharma Co. Ltd. - Overview
Exhibits109: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits110: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits111: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits112: Takara Bio Inc. - Overview
Exhibits113: Takara Bio Inc. - Product / Service
Exhibits114: Takara Bio Inc. - Key news
Exhibits115: Takara Bio Inc. - Key offerings
Exhibits116: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits117: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits120: Terumo Corp. - Overview
Exhibits121: Terumo Corp. - Business segments
Exhibits122: Terumo Corp. - Key news
Exhibits123: Terumo Corp. - Key offerings
Exhibits124: Terumo Corp. - Segment focus
Exhibits125: Yokogawa Electric Corp. - Overview
Exhibits126: Yokogawa Electric Corp. - Business segments
Exhibits127: Yokogawa Electric Corp. - Key news
Exhibits128: Yokogawa Electric Corp. - Key offerings
Exhibits129: Yokogawa Electric Corp. - Segment focus
Exhibits130: Inclusions checklist
Exhibits131: Exclusions checklist
Exhibits132: Currency conversion rates for US$
Exhibits133: Research methodology
Exhibits134: Information sources
Exhibits135: Data validation
Exhibits136: Validation techniques employed for market sizing
Exhibits137: Data synthesis
Exhibits138: 360 degree market analysis
Exhibits139: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings